Cargando…
Optimal dose of neostigmine antagonizing cisatracurium-induced shallow neuromuscular block in elderly patients: a randomized control study
BACKGROUND: Residual neuromuscular block after using neuromuscular blocking agents is a common and potentially harmful complication of general anesthesia. Neostigmine is a widely used antagonist, but its optimal dose for elderly patients is unclear. OBJECTIVES: To compare the optimal dosage and safe...
Autores principales: | Cao, Mengya, Huang, Huifan, Tong, Jianbin, Ou, Yangwen, Liao, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413529/ https://www.ncbi.nlm.nih.gov/pubmed/37563623 http://dx.doi.org/10.1186/s12871-023-02233-7 |
Ejemplares similares
-
A comparison between cisatracurium and rocuronium-induced neuromuscular block on laryngeal electromyography recovery after neostigmine reversal in a porcine model
por: Lu, I-Cheng, et al.
Publicado: (2022) -
Required dose of sugammadex or neostigmine for reversal of vecuronium‐induced shallow residual neuromuscular block at a train‐of‐four ratio of 0.3
por: He, Jing, et al.
Publicado: (2021) -
Effective doses of cisatracurium in the adult and the elderly
por: Kim, Jeong Ho, et al.
Publicado: (2016) -
Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study
por: Carron, M., et al.
Publicado: (2022) -
The effect of low dose ketamine and priming of cisatracurium on the intubating condition and onset time of cisatracurium
por: Ahn, Byung-Ryang, et al.
Publicado: (2012)